Development of a first-in-class neuroprotective drug for protecting the brain after stroke

开发用于保护中风后大脑的一流神经保护药物

• 批准号: nhmrc : GNT1158521
• 负责人: Dr Brad Broughton
• 金额: $ 76.27万
• 依托单位国家: 澳大利亚
• 项目类别: Development Grants
• 财政年份: 2019
• 资助国家: 澳大利亚
• 起止时间: 2019-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/development-first-in-brain-stroke/1349263
• 关键词: Development; first; class; neuroprotective; drug

Every day, more than 150 Australians have a stroke. Stroke is the is the third leading cause of death in Australia and the primary cause of long-term disability. No drugs are currently available to protect the brain from stroke-induced injury. We plan to develop a drug that first responders can administer to stroke patients to provide protection of their brain even before they reach a hospital. Early initiation of stroke treatment will save lives and improve quality of life for stroke survivors.

每天有150多名澳大利亚人中风。中风是澳大利亚第三大死亡原因，也是造成长期残疾的主要原因。目前还没有药物可以保护大脑免受中风引起的损伤。我们计划开发一种药物，让急救人员可以在中风患者到达医院之前就给他们的大脑提供保护。早期开始中风治疗将挽救生命并改善中风幸存者的生活质量。